RSV and Vaccine Hesitancy

RSV and Vaccine Hesitancy

Up next

Highlights from the 2026 ATS Conference

Host Daniel Culver, DO, is joined by Cleveland Clinic pulmonologists Rachel Scheraga, MD, and Vickram Tejwani, MD, for a recap of the 2026 American Thoracic Society Conference (ATS). They discuss key scientific and clinical highlights, including support for early-career investiga ...  Show more

Hypercapnic Respiratory Failure from the Hospitalist Perspective: Recognition, Risk, and Perioperative Insights

In this episode of Respiratory Exchange, Dr. Dan Culver speaks with hospitalist and anesthesia outcomes researcher Dr. Roop Kaw about the practical recognition and management of hypercapnic respiratory failure across the inpatient setting. The discussion explores how hospitalists ...  Show more

Recommended Episodes

HIV immunology for Vaccine Design
HIV

Dr Seph Borrow tells us how her research on HIV Immunology helps design better vaccines. There is an urgent need for vaccines to combat persistent infections like HIV. The earliest interactions between HIV and host immune responses determine the course of the disease. Dr Seph Bor ...  Show more

171 - Two Vax's and a MAB: What's New in RSV Prevention
HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

In this episode, we briefly review RSV (respiratory syncytial virus) infections and focus on new data supporting the use of two different RSV vaccines (Abrysvo and Arvexy) in preventing RSV infections in older adults and in pregnant women. Key Concepts RSV is a contagious respira ...  Show more

The Road Ahead: From Maternal Vaccine Development to Administration
The Antigen

Protection from serious infant illnesses isn’t enough. Helping prevent the disease from happening altogether is the goal of physician-scientists, like Dr. Bill Gruber. As the Senior Vice President of Pfizer Vaccine Clinical Research and Development, Bill explains how maternal vac ...  Show more

Demystifying the Vaccine
Chasing Life

A recent vaccine trial from Oxford University shows promising preliminary results, suggesting the vaccine can produce immune responses that may protect people against infection. Dr. Sanjay Gupta spoke with Dr. Barney Graham, the deputy director of the Vaccine Research Center at t ...  Show more